Sandoz Group (OTCMKTS:SDZNY) Shares Gap Up – What’s Next?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $85.80, but opened at $89.85. Sandoz Group shares last traded at $89.30, with a volume of 1,912 shares trading hands.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on SDZNY. Royal Bank Of Canada cut Sandoz Group from a “moderate buy” rating to a “hold” rating in a research note on Monday, March 23rd. The Goldman Sachs Group raised Sandoz Group to a “strong-buy” rating in a research report on Wednesday, April 1st. Finally, Barclays upgraded Sandoz Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.

Sandoz Group Stock Performance

The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.77 and a current ratio of 1.18. The firm’s 50-day moving average is $83.32 and its 200-day moving average is $80.34.

About Sandoz Group

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.